Whalen Wealth Management Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1894447
LAS VEGAS, NV
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,038,712
+$187,409 QoQ
Shares Held
6,163
-4.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#393
of 768 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Whalen Wealth Management Inc. holds $2,484,690 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (41.8% of the industry book) .
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,038,712 | 6,163 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $851,303 | 6,462 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $726,878 | 5,125 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $626,375 | 4,462 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $456,129 | 3,629 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $375,376 | 3,394 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $263,854 | 1,933 | Shares | Sole | 2025-01-17 | |
| No filing history on record for this holder in this stock. | ||||||